Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Sees Diversifying In China As Key To Success; Expands Capacity For Diabetes Treatment Lantus

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Sanofi-Aventis announced a series of expansion plans in China aimed at diversifying its portfolio, the CEO said April 21 during his first trip to China
Advertisement

Related Content

Novo Nordisk Fights Back Dipping Sales In China By Expanding R&D, Manufacturing Capacity
Sanofi China GM Fabrice Baschiera On Winning The Insulin Battle In China: An Interview With PharmAsia News (Part 2 of 2)
Sanofi-Aventis Outpaces Other International Drug Players In High-speed Growth In China
Merck Sharp & Dohme Launches Januvia In China To Join Race In Second-Largest Diabetes Market
Merck Sharp & Dohme Launches Januvia In China To Join Race In Second-largest Diabetes Market
Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
Sanofi-Aventis China R&D Head Jiang On Fast And Furious Adaptation In China
China's Changing Drug Market In The Wake Of Essential Drugs List
Lilly Launches Byetta In China To Target World's Second Largest Diabetes Market
Emerging Markets Will Lead World Healthcare Market Growth, With China’s Healthcare Reform Shuffling Drug Distribution: Shanghai Bio-Forum
Advertisement
UsernamePublicRestriction

Register

SC071444

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel